IQV - IQVIA Holdings Inc
Close
251.55
0.760 0.302%
Share volume: 1,194,435
Last Updated: Fri 30 Aug 2024 10:00:03 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$250.79
0.76
0.30%
View ratios
Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
Report Date | 2022-10-27 | 2023-02-15 | 2023-04-28 | 2023-08-01 | 2023-11-01 | 2024-02-15 | 2024-05-02 | 2024-07-22 | |
Assets | |||||||||
Total Assets | 24.223 B | 25.337 B | 25.739 B | 26.036 B | 25.977 B | 26.681 B | 26.574 B | 26.398 B | |
Current Assets | 4.752 B | 4.981 B | 5.328 B | 5.329 B | 5.208 B | 5.596 B | 5.651 B | 5.622 B | |
Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Other Current Assets | 791.000 M | 805.000 M | 729.000 M | 763.000 M | 708.000 M | 807.000 M | 746.000 M | 781.000 M | |
Short Term Investments | 791.000 M | 805.000 M | 729.000 M | 763.000 M | 708.000 M | 807.000 M | 746.000 M | 781.000 M | |
Total Receivables | 2.687 B | 2.960 B | 3.105 B | 3.184 B | 3.276 B | 3.413 B | 3.461 B | 3.296 B | |
Current Cash | 1.274 B | 1.216 B | 1.494 B | 1.382 B | 1.224 B | 1.376 B | 1.444 B | 1.545 B | |
Total Non-current Assets | 19.471 B | 20.356 B | 20.411 B | 20.707 B | 20.769 B | 21.085 B | 20.923 B | 20.776 B | |
Property Plant Equipment | 507.000 M | 532.000 M | 520.000 M | 510.000 M | 498.000 M | 523.000 M | 513.000 M | 503.000 M | |
Other Assets | 488.000 M | 472.000 M | 468.000 M | 435.000 M | 459.000 M | 455.000 M | 476.000 M | 478.000 M | |
Intangible Assets | 4.718 B | 4.820 B | 4.757 B | 4.942 B | 4.907 B | 4.839 B | 4.725 B | 4.608 B | |
Goodwill | 13.177 B | 13.921 B | 14.015 B | 14.178 B | 14.288 B | 14.567 B | 14.516 B | 14.477 B | |
Liabilities and shareholders’ equity | |||||||||
Total Liabilities and shareholders’ equity | 24.223 B | 25.337 B | 25.739 B | 26.036 B | 25.977 B | 26.681 B | 26.574 B | 26.398 B | |
Total liabilities | 18.876 B | 19.572 B | 19.807 B | 20.288 B | 20.172 B | 20.569 B | 20.230 B | 19.684 B | |
Total current liabilities | 5.253 B | 5.578 B | 6.657 B | 6.543 B | 6.589 B | 6.491 B | 6.448 B | 6.620 B | |
Accounts Payable | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Other liabilities | 561.000 M | 671.000 M | 641.000 M | 703.000 M | 679.000 M | 698.000 M | 595.000 M | 632.000 M | |
Current long term debt | 151.000 M | 152.000 M | 1.343 B | 1.344 B | 1.309 B | 718.000 M | 717.000 M | 1.167 B | |
Long term debt | 12.243 B | 12.595 B | 11.833 B | 12.433 B | 12.322 B | 12.955 B | 12.819 B | 12.091 B | |
Other liabilities | 561.000 M | 671.000 M | 641.000 M | 703.000 M | 679.000 M | 698.000 M | 595.000 M | 632.000 M | |
Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Total Shareholder equity | 5.347 B | 5.765 B | 5.932 B | 5.748 B | 5.805 B | 6.112 B | 6.344 B | 6.714 B | |
Common stock | 186.500 M | 185.600 M | 185.800 M | 184.400 M | 182.900 M | 182.100 M | 181.900 M | 182.200 M | |
Retained earnings | 3.107 B | 3.334 B | 3.623 B | 3.920 B | 4.223 B | 4.692 B | 4.980 B | 5.343 B |